Safety of growth hormone
- 12 January 1991
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 337 (8733) , 108-110
- https://doi.org/10.1016/0140-6736(91)90764-g
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Treatment of short stature in renal disease with recombinant human growth hormone.Archives of Disease in Childhood, 1990
- The Effects of Treatment with Recombinant Human Growth Hormone on Body Composition and Metabolism in Adults with Growth Hormone DeficiencyNew England Journal of Medicine, 1989
- Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in NorwayInternational Journal of Cancer, 1989
- The delayed effect of growth hormone on renal function in humansKidney International, 1989
- Breast Cancer Risk in Relation to Serum Cholesterol, Serum Beta-Lipoprotein, Height, Weight, and Blood PressureActa Oncologica, 1988
- Effect of growth hormone on short normal children.BMJ, 1987
- Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.Journal of Clinical Investigation, 1986
- Familial Dependence of the Resting Metabolic RateNew England Journal of Medicine, 1986
- Familial juvenile nephronophthisis, Jeune's syndrome, and associated disorders.Archives of Disease in Childhood, 1985